HBV-IN-13
HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor. From patent WO2021204252A1, compound 1_B[1].
Product Specifications
CAS Number
[2724228-72-0]
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-13.html
Solubility
10 mM in DMSO
Smiles
CC([C@H]1N2C(C3=C(C1)C=C(OCCCOC)C4=C3OCO4)=CC(C(C(O)=O)=C2)=O)C
Molecular Formula
C22H25NO7
Molecular Weight
415.44
References & Citations
[1]Tetracyclic compound as hepatitis b surface antigen inhibitor. WO2021204252A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
213596-01 20 µL
STAT2, phosphorylated (Y690) (Signal Transducer and Activator of Transcription 2, P113, ISGF-3, STAT113) discontinued
Ask
View Details 213596-02 100 µL
STAT2, phosphorylated (Y690) (Signal Transducer and Activator of Transcription 2, P113, ISGF-3, STAT113) discontinued
Ask
View Details 
